News
Drugmaker Sanofi said on Thursday it believes the impact from U.S. tariffs to be manageable as it raised its sales growth ...
France's Sanofi said on Thursday that it expects annual sales to grow by high single-digit percentage, helped by strong ...
For now, Sanofi’s U.S. inventory is insulating the company from a potential 15% tariff on drugs shipped from the EU.
August 1 (Reuters) -European stocks hit a 3-week low on Friday at the end of a busy week as investors worried about the ...
Regeneron-partnered Dupixent, the crown jewel of Sanofi’s commercial portfolio, continued to impress with 21.1% sales growth ...
Online availability of Sanofi’s half-year financial report for 2025 Paris, July 31, 2025. Sanofi announces that its half-year financial report for the period ending June 30, 2025 is now available and ...
Baghdad (IraqiNews.com) – The Iraqi Ministry of Health mentioned on Sunday that the agreement with Sanofi, a French ...
Investing.com -- Sanofi (EPA: SASY) shares fell more than 2% on Thursday after the pharmaceutical and healthcare company ...
Paris: Sanofi has received orphan drug designation from the US Food and Drug Administration (FDA) for SAR446523, an ...
Ltd., widely known as Baurs, a leading conglomerate with diversified business interests in Sri Lanka and a pioneer and innovator in various industry verticals, celebrates its 80th anniversary this ...
Health Ministry and Sanofi Egypt have signed a cooperation protocol to promote natural births and reduce unnecessary caesarean deliveries, as per an official statement from the ministry on Tuesday, ...
19h
Zacks Investment Research on MSNSanofi Q2 Earnings & Sales Miss, 2025 Top-Line View Raised, Stock DownSanofi SNY reported second-quarter 2025 adjusted earnings of 90 cents per American depositary share, which missed the Zacks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results